Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali-Reference-Cited by-同舟云学术

Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali

Published:2015-11-09 Issue:suppl_5 Volume:61 Page:S578-S585
ISSN:1537-6591
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Basta Nicole E.,Borrow Ray,Berthe Abdoulaye,Onwuchekwa Uma,Dembélé Awa Traoré Eps,Almond Rachael,Frankland Sarah,Patel Sima,Wood Daniel,Nascimento Maria,Manigart Olivier,Trotter Caroline L.,Greenwood Brian,Sow Samba O.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/61/suppl_5/S578/20914110/civ513.pdf

Reference22 articles.

1. Protein carriers of conjugate vaccines: characteristics, development, and clinical trials;Hum Vaccin Immunother,2013

2. The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?;Philos Trans R Soc Lond B Biol Sci,2013

3. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines;Nat Rev Immunol,2009

4. Effect of a serogroup A meningococcal conjugate vaccine (MenAfriVac®) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected];Lancet,2014

5. Development of a group A meningococcal conjugate vaccine, MenAfriVac;Hum Vaccin Immunother,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and immunogenicity of a single dose of Tdap compared to Td in pregnant women in Mali and 3 its effect on infant immune responses: a single-centre, randomised, double-blind, active-controlled phase 2 study;eClinicalMedicine;2024-05

2. Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children?;Vaccines;2023-03-15

3. Field investigation of high reported non-neonatal tetanus burden in Uganda, 2016–2017;International Journal of Epidemiology;2023-02-10

4. Tetanus Toxoid;Plotkin's Vaccines;2023

5. Sustaining Maternal and Neonatal Tetanus Elimination (MNTE) in countries that have been validated for elimination – progress and challenges;BMC Public Health;2022-04-08